Stroke

 

Timing of Atrial Fibrillation Can Help Predict Stroke Risk

October 04, 2021

Data from more than 800 patients with 120 days of continuous heart monitoring data and ischemic stroke provide insight into the timing of arrhythmic episodes and how it can help predict the risk of stroke in patients with CIEDs and atrial fibrillation.

As Insulin Resistance Increases, So Does Stroke Risk in Patients with Diabetes

September 30, 2021

Data from a recent analysis suggests patients with diabetes with the lowest levels of insulin resistance had a 40% lower risk of stroke when compared to those with the highest levels.

Amplatzer Talisman PFO Occluder and Delivery Sheath Get Nods from FDA

September 30, 2021

Abbott announced on September 29 the FDA had granted approval to the Amplatzer Talisman PFO Occluder for use in patients with a PFO at risk of recurrent stroke. This approval was accompanied by the clearance of the Amplatzer Talisman Delivery Sheath.

Diabetes Medications and Stroke Prevention, With Silvio Inzucchi, MD

September 16, 2021

After presenting at TMIOA's 5th Heart in Diabetes meeting, Silvio Inzucchi, MD, reviews current knowledge related to the effects of diabetes medications on stroke risk.

ESC Congress 2021 Expert Perspective: Top 5 Studies With Brett Nowlan, MD

September 02, 2021

Practical Cardiology editorial advisory board member Brett Nowlan, MD, compiled a top 5 list of studies he thought were noteworthy from ESC Congress 2021 and offers his perspective on why he chose each study.

ESC Congress 2021: Top Trials Slideshow

August 31, 2021

Every year, ESC Congress provides clinicians and researchers with a glimpse into the latest data from clinical trials. Our editorial staff's top picks for new trials from ESC Congress 2021 conference includes EMPEROR-Preserved, FIGARO-DKD, SSaSS, MASTER DAPT, and the LOOP Study.

Amplatzer Amulet Outperforms Watchman Device for LAA Occlusion in Head-to-Head Trial

August 30, 2021

The Amulet IDE Trial is the first trial to offer a head-to-head comparison of the Amplatzer Amulet occluder from Abbot against the Watchman device from Boston Scientific for left atrial appendage occlusion.

Use of Salt Substitute Could Reduce Risk of Stroke, Cardiovascular Events, and Death

August 29, 2021

Data from the Salt Substitute and Stroke Study suggest switching from regular salt to a salt substitute could reduce the risk of stroke by 14% and investigators believe these results can be applied to patient populations across the world.

Continuous Monitoring for AFib Does Not Significantly Reduce Stroke Risk

August 29, 2021

Despite increasing detection of atrial fibrillation and rates of anticoagulation, continuous electrocardiographic monitoring with an implantable loop recorder did not significantly reduce risk of stroke in the LOOP study.

Deepak Bhatt, MD: Icosapent Ethyl Reduces Event Risk in Patients with Prior Myocardial Infarction

August 28, 2021

An ESC Congress 2021 analysis suggests icosapent ethyl was associated with a 35% reduction in total primary end point events among patients with a history of myocardial infarction prior to enrollment in the REDUCE-IT trial.